Aimei Health Technology (AFJK) Competitors

Easterly Government Properties has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Comparatively, Aimei Health Technology has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500.

Easterly Government Properties presently has a consensus price target of $23.49, indicating a potential upside of 1.07%. Given Easterly Government Properties' stronger consensus rating and higher possible upside, analysts plainly believe Easterly Government Properties is more favorable than Aimei Health Technology.

Easterly Government Properties has a net margin of 3.22% compared to Aimei Health Technology's net margin of 0.00%. Easterly Government Properties' return on equity of 0.82% beat Aimei Health Technology's return on equity.

86.5% of Easterly Government Properties shares are owned by institutional investors. Comparatively, 45.6% of Aimei Health Technology shares are owned by institutional investors. 6.5% of Easterly Government Properties shares are owned by company insiders. Comparatively, 2.5% of Aimei Health Technology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Easterly Government Properties had 3 more articles in the media than Aimei Health Technology. MarketBeat recorded 5 mentions for Easterly Government Properties and 2 mentions for Aimei Health Technology. Easterly Government Properties' average media sentiment score of 0.53 beat Aimei Health Technology's score of 0.25 indicating that Easterly Government Properties is being referred to more favorably in the media.

Easterly Government Properties has higher revenue and earnings than Aimei Health Technology. Easterly Government Properties is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

Aimei Health Technology has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500. Comparatively, Safehold has a beta of 1.87, meaning that its stock price is 87% more volatile than the S&P 500.

Safehold has a consensus price target of $19.00, indicating a potential upside of 29.68%. Given Safehold's stronger consensus rating and higher possible upside, analysts plainly believe Safehold is more favorable than Aimei Health Technology.

Safehold has a net margin of 28.58% compared to Aimei Health Technology's net margin of 0.00%. Safehold's return on equity of 4.78% beat Aimei Health Technology's return on equity.

45.6% of Aimei Health Technology shares are held by institutional investors. Comparatively, 70.4% of Safehold shares are held by institutional investors. 2.5% of Aimei Health Technology shares are held by insiders. Comparatively, 3.8% of Safehold shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Safehold had 10 more articles in the media than Aimei Health Technology. MarketBeat recorded 12 mentions for Safehold and 2 mentions for Aimei Health Technology. Aimei Health Technology's average media sentiment score of 0.25 beat Safehold's score of 0.08 indicating that Aimei Health Technology is being referred to more favorably in the media.

Safehold has higher revenue and earnings than Aimei Health Technology. Safehold is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

Permian Basin Royalty Trust has a net margin of 89.06% compared to Aimei Health Technology's net margin of 0.00%. Permian Basin Royalty Trust's return on equity of 8,774.67% beat Aimei Health Technology's return on equity.

In the previous week, Aimei Health Technology and Aimei Health Technology both had 2 articles in the media. Permian Basin Royalty Trust's average media sentiment score of 1.46 beat Aimei Health Technology's score of 0.25 indicating that Permian Basin Royalty Trust is being referred to more favorably in the news media.

Aimei Health Technology has a beta of 0.46, indicating that its share price is 54% less volatile than the S&P 500. Comparatively, Permian Basin Royalty Trust has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500.

Permian Basin Royalty Trust has higher revenue and earnings than Aimei Health Technology. Permian Basin Royalty Trust is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

45.6% of Aimei Health Technology shares are held by institutional investors. Comparatively, 28.9% of Permian Basin Royalty Trust shares are held by institutional investors. 2.5% of Aimei Health Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Empire State Realty Trust has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Comparatively, Aimei Health Technology has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500.

Empire State Realty Trust has higher revenue and earnings than Aimei Health Technology. Empire State Realty Trust is trading at a lower price-to-earnings ratio than Aimei Health Technology, indicating that it is currently the more affordable of the two stocks.

67.1% of Empire State Realty Trust shares are owned by institutional investors. Comparatively, 45.6% of Aimei Health Technology shares are owned by institutional investors. 15.2% of Empire State Realty Trust shares are owned by insiders. Comparatively, 2.5% of Aimei Health Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Empire State Realty Trust had 16 more articles in the media than Aimei Health Technology. MarketBeat recorded 18 mentions for Empire State Realty Trust and 2 mentions for Aimei Health Technology. Empire State Realty Trust's average media sentiment score of 1.03 beat Aimei Health Technology's score of 0.25 indicating that Empire State Realty Trust is being referred to more favorably in the media.

Empire State Realty Trust has a net margin of 5.09% compared to Aimei Health Technology's net margin of 0.00%. Empire State Realty Trust's return on equity of 2.20% beat Aimei Health Technology's return on equity.

Empire State Realty Trust presently has a consensus price target of $6.35, indicating a potential upside of 14.93%. Given Empire State Realty Trust's stronger consensus rating and higher possible upside, analysts plainly believe Empire State Realty Trust is more favorable than Aimei Health Technology.